Mengli Jin

Changchun, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

The protective effect of Schisandrin C against methicillin-resistant Staphylococcus aureus-induced otitis media.

The protective effect of Schisandrin C against methicillin-resistant Staphylococcus aureus-induced otitis media.

Journal: Antimicrobial agents and chemotherapy

Published: June 10, 2026

Prim-O-glucosylcimifugin targets Staphylococcus aureus caseinolytic protease P to inhibit α-hemolysin expression and promote healing of MRSA-induced diabetic skin infections.

Prim-O-glucosylcimifugin targets Staphylococcus aureus caseinolytic protease P to inhibit α-hemolysin expression and promote healing of MRSA-induced diabetic skin infections.

Journal: Microbial pathogenesis

Published: October 24, 2025

Helicid: A novel Anti-Staphylococcus aureus adjuvant.

Helicid: A novel Anti-Staphylococcus aureus adjuvant.

Journal: Biochimie

Published: September 11, 2024

Daphnetin weakened the pathogenicity of methicillin-resistant Staphylococcus aureus by inhibiting Sortase A and α-hemolysin.

Daphnetin weakened the pathogenicity of methicillin-resistant Staphylococcus aureus by inhibiting Sortase A and α-hemolysin.

Journal: Biochimie

Published: May 14, 2024

Sinigrin reduces the virulence of Staphylococcus aureus by targeting coagulase.

Sinigrin reduces the virulence of Staphylococcus aureus by targeting coagulase.

Journal: Microbial pathogenesis

Published: April 09, 2024

Bilobetin attenuates Staphylococcus aureus virulence by targeting Von Willebrand factor-binding protein and staphylocoagulase.

Bilobetin attenuates Staphylococcus aureus virulence by targeting Von Willebrand factor-binding protein and staphylocoagulase.

Journal: World journal of microbiology & biotechnology

Published: August 19, 2023

Isovanillic acid protects mice against Staphylococcus aureus by targeting vWbp and Coa.

Isovanillic acid protects mice against Staphylococcus aureus by targeting vWbp and Coa.

Journal: Future microbiology

Published: August 01, 2023

Ayanin, a natural flavonoid inhibitor of Caseinolytic protease, is a promising therapeutic agent to combat methicillin-resistant Staphylococcus aureus infections.

Ayanin, a natural flavonoid inhibitor of Caseinolytic protease, is a promising therapeutic agent to combat methicillin-resistant Staphylococcus aureus infections.

Journal: Biochemical pharmacology

Published: May 30, 2023

Oroxylin a glucuronide as a novel class of reversible inhibitors of Sortase a, combats MRSA-induced infections.

Oroxylin a glucuronide as a novel class of reversible inhibitors of Sortase a, combats MRSA-induced infections.

Journal: Journal of applied microbiology

Published: January 20, 2023

Punicalagin, an Inhibitor of Sortase A, Is a Promising Therapeutic Drug to Combat Methicillin-Resistant Staphylococcus aureus Infections.

Punicalagin, an Inhibitor of Sortase A, Is a Promising Therapeutic Drug to Combat Methicillin-Resistant Staphylococcus aureus Infections.

Journal: Antimicrobial agents and chemotherapy

Published: June 02, 2022

7,8-Dihydroxyflavone attenuates the virulence of Staphylococcus aureus by inhibiting alpha-hemolysin.

7,8-Dihydroxyflavone attenuates the virulence of Staphylococcus aureus by inhibiting alpha-hemolysin.

Journal: World journal of microbiology & biotechnology

Published: March 28, 2022

Solamargine Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma by Decreasing LncRNA HOXA11-As Expression.

Solamargine Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma by Decreasing LncRNA HOXA11-As Expression.

Journal: Frontiers in pharmacology

Published: March 01, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026